shutterstock_1528056221_jhvephoto

JHVEphoto / Shutterstock.com

23 September 2021AmericasAlex Baldwin

PTAB affirms validity of three Medtronic patents in Axonics suit

The US Patent Trial and Appeal Board (PTAB) has confirmed the validity of three remaining Medtronic patents challenged by rival medical device manufacturer Axonics.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

More on this story

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

More on this story

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York